Armata Pharmaceuticals

ARMPNYSE United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$172.908 M

$4.71 +0.21%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$173.8M

Loss-making

Shares outstanding

36,632,775

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances) — ranked by market cap

All 160 →

#100Outlook TherapeuticsOTLK$190.7M
#101Acumen PharmaceuticalsABOS$176.2M
#102Armata PharmaceuticalsARMP$172.9M
#103LENZ TherapeuticsLENZ$168.1M
#104Cardiol TherapeuticsCRDL$163.7M

Where these numbers come from

Share counts and financials for Armata Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.